Multitarget AD inhibitor-2 (Compound VN-19) is a multitargeting inhibitor acetylcholinesterase (AChE, IC50=0.14 µM), butyrylcholinesterase (BChE, IC50=11.6 µM), monoamine oxidase B (MAO B, IC50=0.45 µM). Multitarget AD inhibitor-2 inhibits self-induced aggregation of amyloid beta protein Abeta1-42 (inhibition rate is 47.3% at 20 µM), and downregulates the level of ROS in SH-SY5Y (80 inhibition rate at 25 µM). Multitarget AD inhibitor-2 ameliorates the cognitive decline in Scopolamine (HY-N0296)-induced Alzheimers Disease zebrafish models[1].
Molekulargewicht:
365.42
Formel:
C22H23NO4
Target-Kategorie:
Cholinesterase (ChE),Monoamine Oxidase
Anwendungsbeschreibung:
Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
